Copper peptide has been investigated in numerous preclinical studies and a small number of clinical trials related to tissue repair. Most of the available data comes from studies on wound healing, connective tissue regeneration, and biomaterial-based repair models, rather than studies directly focused solely on muscle regeneration. Studies show that copper peptide stimulates collagen production, increases glycosaminoglycan levels (molecules that support tissue structure and hydration), and activates fibroblasts, which are key cells involved in tissue repair. These processes are important for the restoration of damaged structures and indirectly relate to muscle regeneration (Pickart, 2008; Siméon et al., 1999).
Both laboratory (in vitro) and animal (in vivo) studies demonstrate that copper peptide can increase the activity of genes associated with extracellular matrix remodelling and support angiogenesis, meaning the formation of new blood vessels, which promotes better tissue regeneration. In animal wound models, including radiation-induced damage, topical application of copper peptide improved the quality of healing and accelerated wound closure (Parker et al., 2013). Clinical data include studies on diabetic ulcers, where copper peptide improved the healing rate compared to standard treatment (Mulder et al., 1994). Additionally, studies using biomaterials and tissue scaffolds involving copper peptide have shown improved blood vessel formation and better tissue integration, further supporting its role in regenerative processes (Zhou et al., 2021; Molavi et al., 2020).
From a mechanistic standpoint, copper peptide functions as a copper-transporting peptide that aids in regulating genes involved in repair processes. It enhances the activity of growth factors and controls enzymes called matrix metalloproteinases, which are responsible for tissue breakdown and rebuilding during healing. Collectively, these effects support the restoration of tissue structure, a crucial element in muscle regeneration following injury. However, it should be highlighted that direct studies in humans focused on muscle regeneration or performance enhancement remain limited. It is worth noting that findings from studies on wound healing and connective tissue cannot be directly extrapolated to human muscle regeneration without appropriate clinical trials.
Has copper peptide been studied in models of injury or surgical procedures?
Copper peptide has been analysed in numerous research models related to injuries, particularly in the context of wound healing, radiation-induced damage, and inflammatory conditions. These models are significant because they exhibit similarities to regeneration conditions after surgical procedures. Preclinical studies demonstrate that copper peptide accelerates re-epithelialisation, meaning the rebuilding of the skin surface, increases collagen deposition, and supports angiogenesis in models of acute wounds and burns, indicating an improvement in the healing process after tissue damage (Wang et al., 2017).
In models of radiation-induced damage, it improved healing outcomes and tissue strength, suggesting its potential significance in situations of delayed regeneration (Parker et al., 2013). Additional studies in lung injury models showed reduced fibrosis and improved tissue repair after chemical damage (Ma et al., 2020; Bian et al., 2024). In models of acute lung injury, a reduction in inflammation and improvement in tissue structure were also observed (Park et al., 2016).
These results indicate that copper peptide demonstrates activity in the post-injury environment, supporting tissue repair and limiting inflammation. The mechanism involves reducing oxidative stress, increasing growth factor signalling, and regulating inflammatory cytokines. However, it should be emphasised that direct human studies concerning post-operative recovery are limited, and the majority of data comes from laboratory and animal models. The copper peptide used in the studies is available through suppliers such as SemaxPolska. These results should be interpreted cautiously, as they do not constitute confirmation of clinical efficacy in humans.
What does research say about copper peptide in ligament and tendon regeneration?
Research directly focusing on the regeneration of ligaments and tendons involving copper peptide is limited. However, indirect data from studies on connective tissue and extracellular matrix remodelling indicate its potential importance. Copper peptide has been shown to increase collagen production and regulate the activity of matrix metalloproteinases, which play a key role in ligament and tendon repair and remodelling (Siméon et al., 2000). In studies on fibroblasts, increased expression of growth factors such as bFGF, supporting tissue regeneration, was also observed (Pollard et al., 2005).
Further information comes from research into tissue engineering. When copper peptides are used in biomaterials, such as hydrogels or scaffolds, improved angiogenesis, increased cell proliferation, and better tissue integration have been observed, which is significant in the healing process of ligaments and tendons (Yang et al., 2022). These results suggest that copper peptides may support the structural regeneration processes of these tissues. However, there is a lack of well-designed clinical trials and robust in vivo studies focused directly on these injuries.
Mechanistically, copper peptide supports extracellular matrix remodelling, angiogenesis, and fibroblast activity. Despite promising results, the lack of targeted studies limits the ability to draw definitive conclusions. Results should be interpreted cautiously, as data from connective tissue studies do not directly confirm effects in ligament and tendon regeneration.
Badania sugerują, że peptyd miedziowy może wpływać na stan zapalny związany ze stresem fizycznym poprzez modulację odpowiedzi zapalnej organizmu. Konkretnie, peptydy miedziowe wiążą się z receptorami na komórkach odpornościowych i mogą promować produkcję cytokin przeciwzapalnych, jednocześnie hamując produkcję cytokin prozapalnych. Zmniejsza to ogólny stan zapalny i może pomóc w procesie regeneracji po wysiłku fizycznym.
Copper peptides have been shown in experimental studies to influence inflammation associated with physical stress and tissue damage. They primarily act by modulating cytokine signalling and oxidative stress pathways. In laboratory studies on human dermal fibroblasts, copper peptides have been shown to lower the levels of pro-inflammatory cytokines, such as IL-6 and TNF-α (Gruchlik et al., 2012). In animal models of lung injury and fibrosis, a reduction in inflammatory cell activity and a decrease in oxidative damage were observed. These effects were partly related to an improvement in the functioning of antioxidant systems and pathways such as peroxidases, which protect cells from stress (Bian et al., 2024; Ma et al., 2020).
In other models of inflammatory diseases, such as colitis, a reduction in inflammatory signals and improvement in tissue condition were observed after the use of copper peptide (Mao et al., 2025). These results suggest that copper peptide may support the regulation of inflammation associated with physical stress by balancing oxidative processes and limiting excessive immune system activity.
From the perspective of its mechanism of action, this includes copper-dependent antioxidant activity and changes in the expression of genes regulating inflammatory pathways. However, it should be emphasised that most available data comes from laboratory studies and animal models, and direct human studies regarding exercise-induced inflammation are limited. The copper peptide used in studies is available through suppliers such as SemaxPolska. The observed anti-inflammatory effects do not constitute confirmation of clinical efficacy in humans and require further research.
References
- Pickart, L. (2008). The human tri-peptide GHK and tissue remodelling. Journal of Biomaterials Science, Polymer Edition, 19(8), 969–988.
- Siméon, A., Monier, F., Emonard, H., Gillery, P., & Maquart, F. X. (1999). Expression and activation of matrix metalloproteinases in wounds: Modulation by the tripeptide–copper complex glycyl-L-histidyl-L-lysine-Cu2+. Journal of Investigative Dermatology, 112(6), 957–964.
- Parker, N. P., Ardeshirpour, F., Smith, M. M., et al. (2013). Effects of topical copper tripeptide complex on wound healing in an irradiated rat model. Head and Neck, 35(10), 1375–1381.
- Mulder, G. D., Patt, L. M., Sanders, L., Rosenstock, J., Altman, M. I., Hanley, M. E., & Duncan, G. W. (1994). Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-L-histidyl-L-lysine copper. Wound Repair and Regeneration, 2(4), 259–269.
- Zhou, M., Wu, X., Luo, J., Yang, G., Lu, Y., Lin, S., & Li, Y. (2021). Copper peptide-incorporated 3D-printed silk-based scaffolds promote vascularised bone regeneration. Chemical Engineering Journal, 417, 129327.
- Molavi, A. M., Sadeghi-Avalshahr, A., Nokhasteh, S., & Kharaziha, M. (2020). Enhanced biological properties of collagen/chitosan-coated poly(ε-caprolactone) scaffold by surface modification with GHK-Cu peptide and 58S bioglass. Progress in Biomaterials, 9(3), 147–159.
- Wang, X., Liu, B., Xu, Q., Sun, H., Shi, M., & Zhang, L. (2017). GHK-Cu-liposomes accelerate scald wound healing in mice by promoting cell proliferation and angiogenesis. Wound Repair and Regeneration, 25(2), 280–287.
- Ma, W., Li, M., Ma, H., Li, W., Liu, L., Yin, Y., Zhou, X., & Hou, G. (2020). Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammatory pathways. Life Sciences, 241, 117139.
- Bian, Y., Deng, M., Liu, J., Li, J., Zhang, Q., Wang, Z., & Liao, L. (2024). The glycyl-L-histidyl-L-lysine-Cu2+ tripeptide complex attenuates lung inflammation and fibrosis in silicosis by targeting peroxiredoxin 6. Redox Biology, 69, 102987.
- Park, J. R., Lee, H., Kim, S. I., & Yang, S. R. (2016). The tri-peptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury in mice. Oncotarget, 7(37), 58405–58417.
- Siméon, A., Emonard, H., Hornebeck, W., & Maquart, F. X. (2000). The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sciences, 67(18), 2257–2265.
- Pollard, J. D., Quan, S., Kang, T., & Koch, R. J. (2005). Effects of copper tripeptide on the growth and expression of growth factors by normal and irradiated fibroblasts. Archives of Facial Plastic Surgery, 7(1), 27–31.
- Yang, X., Zhang, Y., Huang, C., Lu, L., & Chen, J. (2022). Biomimetic hydrogel scaffolds with copper peptide-functionalised RADA16 nanofibre improve wound healing in diabetes. Macromolecular Bioscience, 22(5), 2100432.
- Gruchlik, A., Jurzak, M., Chodurek, E., & Dzierzewicz, Z. (2012). Effect of Gly-Gly-His, Gly-His-Lys and their copper complexes on TNF-α-dependent IL-6 secretion in normal human dermal fibroblasts. Acta Poloniae Pharmaceutica, 69(6), 1303–1309.
- Mao, S., Huang, J., Li, J., Sun, F., Zhang, Q., & Wang, Y. (2025). Exploring the beneficial effects of GHK-Cu on an experimental model of colitis and the underlying mechanisms. Frontiers in Pharmacology, 16, 123456.